Stocktoria
Gevo, Inc. GEVO
Nasdaq · XNAS · stock · Industrial Organic Chemicals · website · IPO 2011-02-09
Gevo, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $160.6M | $16.9M | $17.2M | $1.2M | $711,000 |
| Gross profit | — | — | — | — | -$11.5M |
| R&D expense | $4.5M | $5.6M | $6.6M | $7.4M | $6.8M |
| SG&A expense | — | — | — | — | $25.5M |
| Operating income | -$20.2M | -$90.8M | -$81.8M | -$102.7M | -$60.3M |
| Interest expense | — | — | $2.2M | $1.2M | $251,000 |
| Net income | -$33.8M | -$78.6M | -$66.2M | -$98.0M | -$59.2M |
| EPS (diluted) | $-0.14 | $-0.34 | $-0.28 | $-0.44 | $-0.30 |
| Operating cash flow | -$13.4M | -$57.4M | -$53.7M | -$44.3M | -$48.3M |
| Free cash flow | -$43.5M | -$108.5M | -$108.2M | -$128.4M | -$105.0M |
| Cash & equivalents | $81.2M | $189.4M | $298.3M | $237.1M | $40.8M |
| Inventory | $19.1M | $4.5M | $3.8M | $6.3M | $2.8M |
| Total assets | $718.9M | $583.9M | $650.3M | $700.7M | $645.4M |
| Total liabilities | $247.8M | $94.5M | $92.9M | $95.3M | $98.1M |
| Shareholders' equity | $466.3M | $489.5M | $557.4M | $605.5M | $547.3M |
Source: SEC EDGAR filings · CIK 0001392380 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.